Nanoparticles could deliver drugs to the brain
For patients with malignant brain tumors, the prognosis remains dismal. With the most aggressive treatments available, patients are usually only expected to live about 14 months after a diagnosis.
This is because, chemotherapy, the most common form of treatment for cancer, is uniquely challenging for brain tumor patients. The delicate organ in our skulls is protected by a network of vessels and tissue called the blood-brain barrier that keeps most foreign substances out. Furthermore, chemotherapy drugs can cause significant damage to the rest of the body if they are not able to target the tumor in a pharmacologically significant dose.
These challenges have plagued scientists for years, but a team of researchers for Yale School of Medicine and Beijing Normal University just published a breakthrough study detailing a new method that offers a promise at treatment. The solution? Nanoparticles.
Nanoparticles, particles that are smaller than wavelengths of visible light and can only be seen under a special microscope, have the potential to pass through the blood-brain barrier. They can also carry drugs to targeted areas of the body, reducing the side effects on the rest of the body. But previous nanoparticles were very complex and not very efficient in penetrating in the brain.
This most recent paper, published in Nature Biomedical Engineering on March 30, 2020, describes a small carbon nanoparticle engineered by the two labs that could both deliver chemotherapy drugs across the blood-brain barrier and mark tumor cells with fluorescence in mice. What’s more, this nanoparticle is incredibly simple—made up of only one single compound.
We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.
“The major problems we’ve solved is to improve the delivery efficiency and specificity of nanoparticles,” says Jiangbing Zhou, PhD, associate Professor of Neurosurgery and of Biomedical Engineering at Yale School of Medicine. “We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.”
The GPS-like targeting occurs because the nanoparticles engineered to be recognized by a molecule called LAT1, which is present in the blood-brain barrier as well as many tumors, but not in most other normal organs. As a result, chemotherapy drugs can be loaded on the dots and target tumors while barely affecting the rest of the body. The nanoparticles gain entry to the brain because they’ve been engineered to look like amino acids, which are allowed past the blood-brain barrier as nutrients.
The nanoparticles have wider implications than drug delivery. They can be stimulated to emit a fluorescence, which helps surgeons locate tumor to remove with greater accuracy.
Still, there’s a long road ahead before this research can be applied in a clinical setting, says Dr. Zhou. “It takes a long time before the technology can be translated into clinical applications,” he says. “But this finding suggests a new direction for developing nanoparticles for drug delivery to the brain by targeting LAT1 molecules.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Brain cancer treatment
- Pediatric Brain Tumor Foundation Invites Public to "Name Names" This May During Brain Tumor Awareness Monthon April 30, 2021 at 12:05 pm
In order to humanize the battle against childhood brain tumors, this May during Brain Tumor Awareness Month, the ...
- Former American Idol contestant, 26, details struggle seeking brain cancer diagnosison April 30, 2021 at 9:25 am
While having a tumor the size of a peach in her brain has been an overwhelming experience, Young is relying on music and loved ones to support her.
- Oncology Nurses Provide A Compassionate Connection During Ovarian Cancer Careon April 30, 2021 at 6:45 am
Halla, who provides specialized nursing care at Arizona Oncology, guides women through all facets of ovarian cancer treatment.
- The Importance Of Patient-Centered Clinical Trials In Treating Ovarian Canceron April 30, 2021 at 6:45 am
The expanded use of PARP inhibitors in the treatment of advanced ovarian cancer—in women with or without certain biomarkers—has ensured access to treatment that can extend the amount of time spent in ...
- Optune Device Extends Life Expectancy Of Littleton Man With Brain Canceron April 29, 2021 at 4:23 pm
A man with stage 4 brain cancer is beating the odds. Bruce Stahlman has extended his life expectancy with a treatment at UCHealth: a portable, painless device.
Go deeper with Google Headlines on:
Brain cancer treatment
Go deeper with Bing News on:
Carbon nanoparticle drug delivery
- Applications of nanoparticles in combating COVID-19on April 30, 2021 at 9:51 am
Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.
- Biosensors Market with COVID-19 Impact by Type, Product, Technology, Application and Region - Global Forecast to 2026on April 30, 2021 at 2:19 am
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Biosensors Market with COVID-19 Impact by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, ...
- Cytocompatibility of stabilized black phosphorus nanosheets tailored by directly conjugated polymeric micelles for human breast cancer therapyon April 29, 2021 at 9:30 am
The novel procedure of few-layer black phosphorus (FLBP) stabilization and functionalisation was here proposed. The cationic polymer PLL and non-ionic PEG have been involved into encapsulation of FLBP ...
- Global Biosensors Market (2021 to 2026) - Increasing Use of Biosensors to Monitor Glucose Levels in Individuals with Diabetes is Driving Growthon April 29, 2021 at 8:23 am
The "Biosensors Market with COVID-19 Impact by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, Environmental Monitoring, Food & Beverages, ...
- The Worldwide Biosensors Industry is Projected to Reach $36.7 Billion by 2026 at a CAGR of 7.5% from 2021 – ResearchAndMarkets.comon April 27, 2021 at 5:28 am
The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026. Metal-based nanoparticles ...